Demand for COVID tests has fluctuated during the course of the pandemic and Abbott has recently seen demand decline for its BinaxNOW rapid antigen tests. In the first quarter, the company reported ...
As Abbott shaves down its COVID-related revenue forecasts, so too is the company whittling down its COVID test-making workforce. For the second time this year, Abbott has filed a notice with Maine’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback